TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2014

Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.

Hans H Strøm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.